SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-116249
Filing Date
2021-04-14
Accepted
2021-04-14 16:05:53
Documents
3
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A d352758ddef14a.htm DEF 14A 397166
2 GRAPHIC g352758g18t27.jpg GRAPHIC 36098
3 GRAPHIC g352758g76a76.jpg GRAPHIC 28166
  Complete submission text file 0001193125-21-116249.txt   473306
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38981 | Film No.: 21825771
SIC: 2834 Pharmaceutical Preparations